Is the NHS in more trouble than usual this winter?
As health service chiefs warn of a ‘tidal wave’ of viral infections, Sean O’Grady looks at the causes and implications of the crisis facing our hospitals ...
Becker's Hospital Review3h
Infant RSV vaccine trials on hold: FDA
The FDA has placed a hold on all clinical studies of vaccines for respiratory syncytial virus in infants due to safety concerns following a trial involving two mRNA-based vaccine candidates from ...
clinicaltrialsarena3h
Blue Lake Biotechnology sees success in early RSV vaccine results
Early results from Blue Lake trial found the vaccine to be safe, tolerated and able to cut the chance of contracting the infection.
Business Wire4h
Blue Lake Biotechnology Reports Additional Promising Clinical Data from Ongoing Pediatric Clinical Study of Intranasal RSV Vaccine BLB201
Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company developing parainfluenza virus 5 (PIV5)-vectored ...
kffhealthnews4h
Research Roundup: The Latest Science, Discoveries, And Breakthroughs
CIDRAP: Recombinant Pertussis Vaccine May Protect Teens For At Least 5 Years Researchers report that immunity against pertussis (whooping cough) was sustained 5 years after receipt of a ...
infectiousdiseaseadvisor.com4h
RSV Burden Remains High in Young Children in the United States
The burden of respiratory syncytial virus in young children continues to be high in the United States, according to study findings.
Your winter illness guide: Why norovirus and RSV are on the rise, and what to expect from COVID-19 and the flu
Symptoms of respiratory syncytial virus, or RSV, may start off similar to a common cold, with sneezing and a runny nose. But ...
Department of Health: Respiratory illnesses on the rise in Arkansas
RespiratorySyncytial Virus, or RSV, cases have been skyrocketing in Arkansas. The Arkansas Department of Health released new ...